DIAN, Roche, Foundation in Chinese genomic profiling deal

Foundation Medicine Inc. (NASDAQ:FMI), DIAN Diagnostics Group Co. Ltd. (SZSE:300244) and Roche (SIX:ROG; OTCQX:RHHBY) partnered to

Read the full 165 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE